Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05562557 · ClinicalTrials.gov registry record · NA

A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

A NA study of Substance Use and Child Abuse, sponsored by Montefiore Medical Center.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT05562557: Recruiting NA study of Substance Use and Child Abuse, sponsored by Montefiore Medical Center.

NCT05562557 is a NA study of Substance Use and Child Abuse that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 240 participants, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05562557, a NA study of Substance Use and Child Abuse, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Montefiore will engage fathers in families at risk of substance misuse in the Bronx and neighboring communities. Families will be referred from Bronx and neighboring community-based child welfare systems, substance use disorder (SUD) treatment providers, and medical providers if identified at risk of substance use concerns and will be randomly assigned to receive services as usual as part of the comparison group, or to receive enhanced services as part of the program group. Enhanced services include: (1) Motivational Enhancement; (2) referral to Healthy, Empowered, Resilient, and Open (HERO) Dads fatherhood engagement program; (3) Contingency Management; and (4) Case Management.

Primary Outcome

Child well-being will be assessed by the Child Behavior Checklist. This is a standardized self-report measure widely used in the measure of child behavior and child well-being. Separate forms are used for children aged 1.5-5, and 6-18. The questionnaire is completed by the caregiver using a series of Likert scales (0=absent, 1=sometimes, 2=often occurs). There are 113 questions, measuring a series of internalizing (e.g., anxious/ depressed, depressed, somatic complaints) and externalizing (e.g.,

Interventions

  • BEHAVIORAL Case Management
  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Motivational Enhancement
  • BEHAVIORAL HERO Dads Fatherhood Program

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-05-09
Est. Completion 2027-09
Phase NA
Montefiore Medical Center

345 total trials

What NCT05562557 shows while recruiting

NCT05562557 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (81% lower).

The record links to 5 conditions, with Substance Use appearing as the primary indexed condition, and to 4 interventions - of which Case Management is the first listed.

NCT05562557 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05562557 about?

NCT05562557 is a clinical study titled "A Regional Partnership to Improve Outcomes Through Fatherhood Engagement". Montefiore will engage fathers in families at risk of substance misuse in the Bronx and neighboring communities. Families will be referred from Bronx and neighboring community-based child welfare systems, substance use disorder (SUD) treatment providers, and medical providers if identified at risk o...

What is the current status of trial NCT05562557?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-05-09. Estimated completion is 2027-09.

What conditions does trial NCT05562557 study?

This clinical trial studies the following conditions: Substance Use, Child Abuse, Child Neglect, Fathers, Father-Child Relations.

What interventions are being tested in trial NCT05562557?

The interventions under investigation include: Case Management (BEHAVIORAL), Contingency Management (BEHAVIORAL), Motivational Enhancement (BEHAVIORAL), HERO Dads Fatherhood Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05562557?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05562557 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05562557's enrollment target sits among peer trials

240 40th of 88 higher than 48 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05562557, the US trial registry maintained by the National Library of Medicine. NCT05562557 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.